Loading...

Precipio, Inc.

PRPONASDAQ
Healthcare
Medical - Diagnostics & Research
$14.26
$-0.24(-1.66%)

Precipio, Inc. (PRPO) Financial Performance & Income Statement Overview

Explore the financials of Precipio, Inc. (PRPO), including yearly and quarterly data on income, cash flow, and balance sheets.

Revenue Growth
5.05%
5.05%
Operating Income Growth
44.67%
44.67%
Net Income Growth
26.70%
26.70%
Operating Cash Flow Growth
112.33%
112.33%
Operating Margin
-12.72%
12.72%
Gross Margin
46.14%
46.14%
Net Profit Margin
-8.76%
8.76%
ROE
-15.00%
15.001%
ROIC
-18.09%
18.09%

Precipio, Inc. (PRPO) Income Statement & Financial Overview

Access detailed annual and quarterly income data for Precipio, Inc. PRPO financial performance.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$4.26M$5.45M$5.21M$4.44M
Cost of Revenue$2.12M$2.80M$2.93M$3.02M
Gross Profit$2.14M$2.65M$2.28M$1.42M
Gross Profit Ratio$0.50$0.49$0.44$0.32
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$0.00$2.65M$0.00$2.63M
Operating Expenses$3.00M$2.98M$2.87M$2.63M
Total Costs & Expenses$5.12M$5.79M$5.81M$5.65M
Interest Income$0.00$0.00$0.00$0.00
Interest Expense-$25000.00$29000.00$29000.00$11000.00
Depreciation & Amortization$0.00$382000.00$381000.00$355000.00
EBITDA-$859000.00$46000.00-$216000.00-$854000.00
EBITDA Ratio-$0.20$0.008-$0.04-$0.19
Operating Income-$859000.00-$336000.00-$597000.00-$1.21M
Operating Income Ratio-$0.20-$0.06-$0.11-$0.27
Other Income/Expenses (Net)-$25000.00-$29000.00-$29000.00-$11000.00
Income Before Tax-$884000.00-$365000.00-$626000.00-$1.22M
Income Before Tax Ratio-$0.21-$0.07-$0.12-$0.27
Income Tax Expense$0.00$0.00$0.00$0.00
Net Income-$884000.00-$365000.00-$626000.00-$1.22M
Net Income Ratio-$0.21-$0.07-$0.12-$0.27
EPS-$0.59-$0.25-$0.42-$0.83
Diluted EPS-$0.59-$0.25-$0.42-$0.83
Weighted Avg Shares Outstanding$1.50M$1.47M$1.48M$1.46M
Weighted Avg Shares Outstanding (Diluted)$1.50M$1.47M$1.48M$1.46M

Over the last four quarters, Precipio, Inc. achieved steady financial progress, growing revenue from $4.44M in Q2 2024 to $4.26M in Q1 2025. Gross profit stayed firm with margins at 50% in Q1 2025 versus 32% in Q2 2024. Operating income totaled -$859000.00 in Q1 2025, maintaining a -20% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$859000.00. Net income dropped to -$884000.00, with EPS at -$0.59. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;